Extra JM - Search Results

1

Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study.

Bollet MA, Sigal-Zafrani B, Gambotti L, Extra JM, Meunier M, Nos C, Dendale R, Campana F, Kirova YM, Diéras V, Fourquet A; Institut Curie Breast Cancer Study Group. Bollet MA, et al. Among authors: extra jm. Eur J Cancer. 2006 Sep;42(14):2286-95. doi: 10.1016/j.ejca.2006.03.026. Epub 2006 Aug 8. Eur J Cancer. 2006. PMID: 16893641 Clinical Trial.

2

A review of the antitumour activity of vinorelbine in breast cancer.

Marty M, Extra JM, Dieras V, Giacchetti S, Ohana S, Espié M. Marty M, et al. Among authors: extra jm. Drugs. 1992;44 Suppl 4:29-35; discussion 66-9. doi: 10.2165/00003495-199200444-00004. Drugs. 1992. PMID: 1283848 Review.

3

[Contribution of cytokines in the treatment of human cancers].

Marty M, Extra JM, Dieras V. Marty M, et al. Among authors: extra jm. Pathol Biol (Paris). 1990 Oct;38(8):783-5. Pathol Biol (Paris). 1990. PMID: 1703291 French. No abstract available.

4

5HT3-antagonist receptors: their role in drug-induced emesis.

Dieras V, Extra JM, Le Bonniec M, Madelaine I, Espie M, Marty M. Dieras V, et al. Among authors: extra jm. Nouv Rev Fr Hematol (1978). 1990;32(6):449-52. Nouv Rev Fr Hematol (1978). 1990. PMID: 1983228 Review.

5

[Fundamental and methodologic bases of therapeutic intensification].

Marty M, Extra JM, Dieras V, Espie M. Marty M, et al. Among authors: extra jm. Pathol Biol (Paris). 1989 Nov;37(9):961-4. Pathol Biol (Paris). 1989. PMID: 2608350 French. No abstract available.

6

[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast].

Culine S, Extra JM, Espie M, Bourstyn E, Dieras V, Giacchetti S, Maylin C, De Rocquancourt A, Morvan F, Marty M. Culine S, et al. Among authors: extra jm. Bull Cancer. 1993 Nov;80(11):994-1000. Bull Cancer. 1993. PMID: 8081037 French.

7

Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method.

Dieras V, Extra JM, Bellissant E, Espie M, Morvan F, Pierga JY, Mignot L, Tresca P, Marty M. Dieras V, et al. Among authors: extra jm. J Clin Oncol. 1996 Dec;14(12):3097-104. doi: 10.1200/JCO.1996.14.12.3097. J Clin Oncol. 1996. PMID: 8955654 Clinical Trial.

8

Prospects with docetaxel in the treatment of patients with breast cancer.

Marty M, Extra JM, Cottu PH, Espié M. Marty M, et al. Among authors: extra jm. Eur J Cancer. 1997 Aug;33 Suppl 7:S26-9. doi: 10.1016/s0959-8049(97)90007-1. Eur J Cancer. 1997. PMID: 9486101 Review.

9

Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?

Degeorges A, de Roquancourt A, Extra JM, Espie M, Bourstyn E, de Cremoux P, Soussi T, Marty M. Degeorges A, et al. Among authors: extra jm. Breast Cancer Res Treat. 1998 Jan;47(1):47-55. doi: 10.1023/a:1005824216444. Breast Cancer Res Treat. 1998. PMID: 9493975 Clinical Trial.

10

Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.

Ardavanis A, Extra JM, Espié M, Cuvier C, Marty M. Ardavanis A, et al. Among authors: extra jm. In Vivo. 1998 Sep-Oct;12(5):559-62. In Vivo. 1998. PMID: 9827368 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters